NIHR Bioresource DAA063: This data base contains numerical data in Crohn's disease linking metabolic syndrome to related disease outcomes.
metabolic syndrome obesity fibrosis crohn's disease inflammatory bowel disease related disease outcomes
Imaging and bio-sample data sets related to patients with active and inactive Inflammatory Bowel Disease
Disbiome is a database covering microbial composition changes in different kinds of diseases. Disease names, detection methods or organism names can be used as search queries giving that return inform ...
The Disease Ontology has been developed as a standardized ontology for human disease with the purpose of providing descriptions of human disease terms, phenotype characteristics and related medical vo ...
The IBD Registry captures longitudinal clinical data on IBD patients from NHS Trusts. The dataset includes demographics; diagnosis and phenotype; medications (greater details on biologics); interventi ...
DISNOR is a resource that uses a comprehensive collection of disease associated genes, as annotated in DisGeNET, to interrogate SIGNOR (https://signor.uniroma2.it) in order to assemble disease-specifi ...
Prospective, longitudinal cohort of patients with community liver disease. Patients selected by risk factors and followed for long term clinical outcomes.
Most NIHR BioResource participants complete a self-report form on recruitment. Typically this contains e.g. height, weight, smoking history and alcohol consumption, but also includes questions relati ...
A continuous, record-level dataset of hospital treatment and outcomes of patients with bowel cancer in England and Wales, including patient and tumour characteristics, route to diagnosis, diagnosis, t ...
Our disease ontology provides information on infectious diseases, disease synonyms, transmission pathways, disease agents, affected populations and disease properties. Diseases have been grouped into ...
The NIHR BioResource acquires broad demographics – e.g. age, sex, ethnicity - from participants at recruitment. This is used to pre-screen or match participants when inviting them to take part in exp ...
NIHR BioResource samples are held at the NIHR National Biosample Centre in Milton Keynes. Metadata on what is available should become available through the UK CRC Tissue Directory, as mandated by Rese ...
The NIHR BioResource ran the pilot for GEL's 100,000 Genomes Project. Most of the participants with rare disease were recruited on the basis of having no known diagnosis, and have had extensive work u ...
The NIHR BioResource asks those collecting data on participants as part of sample-only or recall studies to offer data for re-use by others. These offers may be taken up in future.
The NIHR BioResource acquires contact details - name, address, email address, phone/mobile number - from participants at recruitment. This is used to recontact participants to invite them to take part ...
A deeply phenotyped dataset of 61,000 patients being investigated or treated for acute coronary syndrome. Longitudinal linked healthcare utilisation data. Serial physiology readings, lab analysis res ...
Vision and systemic cardiac outcome data for those identified by having a diabetic screening eye test and an acute episode at Queen Elizabeth Hospital, Birmingham. Key data include demographics, longi ...
Cluster randomised controlled trial of chronic kidney disease nurse practitioners in primary care (Nene CCG). Mortality, cardiovascular and endstage renal outcomes available from primary care records ...
The MalaCards human disease database (http://www. malacards.org/) is an integrated compendium of annotated diseases mined from 68 data sources. MalaCards has a web card for each of ∼20 000 disease ent ...
SNP chip data can be used to impute many of the (non-rare) SNPs not included on the chips. The NIHR BioResource is using a modified version of the UK Biobank protocol to improve the options for recal ...
Collection of samples and data across the following diseases: Sjogren's syndrome (disorder) Peripheral blood samples (DNA, RNA, serum, PBMC) from patients with primary Sjogren's syndrome, with detaile ...